NEW YORK, March 15 – Software developer NuTec Sciences announced plans Thursday to make a push into the European life sciences market.

The company said its new office, NuTec Sciences Limited, would be located near Manchester, UK, and named Stephane Labonte managing director in charge of growing NuTec’s life science business and its energy services division in Europe.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Alnylam's RNAi-based therapy Onpattro, according to Stat News.

Harvard Medical School's Seth Cassel and Cigall Kadoch argue in a Baltimore Sun op-ed that the recent TAILORx trial shows the potential of genomic-based medicine.

Researchers in the UK are working on using gene drives to control malaria-carrying mosquitoes, the Telegraph reports.

In PLOS this week: genetic architecture mediating gene expression, metabolomic patterns in multiple myeloma, and more.